Recent Finacing
Recent Raise
Ikarovec develops gene therapies for ophthalmic diseases, advancing a multicistronic candidate for diabetic macular edema in IND-enabling studies and programs for wet/dry AMD and intraocular hypertension.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Ikarovec.
